ARPLEXAM 10/2.5/10 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

arplexam 10/2.5/10 milligram film coated tablet

les laboratoires servier - perindopril arginine, indapamide, amlodipine besilate - film coated tablet - 10/2.5/10 milligram - ace inhibitors, other combinations

MIZOLLEN TABLETS 10 MG Israel - English - Ministry of Health

mizollen tablets 10 mg

pharma shalom - mizolastine - film coated tablets - mizolastine 10 mg - mizolastine - mizolastine - symptomatic treatment of seasonal allergic rhinoconjuctivitis (hay fever), perennial allergic rhino-conjuctivitis and urticaria.

Mizollen 10 mg tabl. modif.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

mizollen 10 mg tabl. modif.-rel.

opella healthcare belgium sa-nv - mizolastine 10 mg - modified-release tablet - 10 mg - mizolastine 10 mg - mizolastine

MIZOLLEN Tablets 10 Milligram Ireland - English - HPRA (Health Products Regulatory Authority)

mizollen tablets 10 milligram

sanofi-aventis ireland limited - mizolastine - tablets - 10 milligram

E-Mycin New Zealand - English - Medsafe (Medicines Safety Authority)

e-mycin

viatris limited - erythromycin ethylsuccinate 46.8 mg/ml equivalent to erythromycin 40 mg/ml (does not include 10% overage) - granules for oral suspension - 200 mg/5ml - active: erythromycin ethylsuccinate 46.8 mg/ml equivalent to erythromycin 40 mg/ml (does not include 10% overage) excipient: aspartame cherry flavour 163837 colloidal silicon dioxide erythrosine propylene glycol alginate sodium benzoate sodium citrate dihydrate sorbitol - streptococcus pyogenes (group a beta-haemolytic streptococcus): upper and lower respiratory tract, skin and soft tissue infections of mild to moderate severity. when oral medication is preferred for treatment of streptococcal pharyngitis and in long term prophylaxis of rheumatic fever, erythromycin is an alternate drug of choice. when oral medication is given, the importance of strict adherence by the patient to the prescribed dosage regimen must be stressed. a therapeutic dose should be administered for at least 10 days. prevention of initial attacks of rheumatic fever: penicillin is considered to be the drug of choice in the prevention of initial attacks of rheumatic fever (treatment of group a beta-haemolytic streptococcal infections of the upper respiratory tract e.g. tonsillitis or pharyngitis). erythromycin is indicated for the treatment of penicillin-allergic patients. the therapeutic dose should be administered for 10 days. prevention of recurrent attacks of rheumatic fever: penicillin or sulphonamides are considered to be the drugs of choice in the prevention of recurrent attacks of rheumatic fever. in patients who are allergic to penicillin and sulphonamides, oral erythromycin is recommended in the long term prophylaxis of streptococcal pharyngitis (for the prevention of recurrent attacks of rheumatic fever).

E-Mycin New Zealand - English - Medsafe (Medicines Safety Authority)

e-mycin

viatris limited - erythromycin ethylsuccinate 93.6 mg/ml equivalent to erythromycin 80 mg/ml (does not include 10% overage) - granules for oral suspension - 400 mg/5ml - active: erythromycin ethylsuccinate 93.6 mg/ml equivalent to erythromycin 80 mg/ml (does not include 10% overage) excipient: aspartame cherry flavour 163837 colloidal silicon dioxide erythrosine propylene glycol alginate sodium benzoate sodium citrate dihydrate sorbitol - streptococcus pyogenes (group a beta-haemolytic streptococcus): upper and lower respiratory tract, skin and soft tissue infections of mild to moderate severity. when oral medication is preferred for treatment of streptococcal pharyngitis and in long term prophylaxis of rheumatic fever, erythromycin is an alternate drug of choice. when oral medication is given, the importance of strict adherence by the patient to the prescribed dosage regimen must be stressed. a therapeutic dose should be administered for at least 10 days. prevention of initial attacks of rheumatic fever: penicillin is considered to be the drug of choice in the prevention of initial attacks of rheumatic fever (treatment of group a beta-haemolytic streptococcal infections of the upper respiratory tract e.g. tonsillitis or pharyngitis). erythromycin is indicated for the treatment of penicillin-allergic patients. the therapeutic dose should be administered for 10 days. prevention of recurrent attacks of rheumatic fever: penicillin or sulphonamides are considered to be the drugs of choice in the prevention of recurrent attacks of rheumatic fever. in patients who are allergic to penicillin and sulphonamides, oral erythromycin is recommended in the long term prophylaxis of streptococcal pharyngitis (for the prevention of recurrent attacks of rheumatic fever).

ARPLEXAM 10/2.5/5 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

arplexam 10/2.5/5 milligram film coated tablet

les laboratoires servier - perindopril arginine, indapamide, amlodipine besilate - film coated tablet - 10/2.5/5 milligram - ace inhibitors, other combinations

ARPLEXAM 5/1.25/10 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

arplexam 5/1.25/10 milligram film coated tablet

les laboratoires servier - perindopril arginine, indapamide, amlodipine besilate - film coated tablet - 5/1.25/10 milligram - ace inhibitors, other combinations

CITALOPRAM 10 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

citalopram 10 milligram film coated tablet

niche generics limited - citalopram hydrobromide citalopram - film coated tablet - 10 milligram